Dr. Chavan is a Founder, CEO, and Board Director level executive with proven international experience in drug development, commercial partnerships, strategy development, operational management, and financial management of life sciences/biotechnology companies. He is a highly motivated, result-oriented diligent team leader, with more than 30 years of biotechnology experience of which the last 22 years have been dedicated to the development of cell-based therapies and biotherapeutic molecules for the treatment of cancer and autoimmunity diseases. He has held several positions of increasing responsibility and has successfully led drug development research programs at Accutest Biologics Pvt. LTD., Celtaxsys, Inc., Forest Life Sciences, Bioquant, and Memorial Sloan Kettering Cancer Center, which resulted in over 50 publications in peer-reviewed journals and 12 U.S. patents.

Over the last decade, Jessica has gained extensive involvement in working within several labs focusing on regenerative medicine. With years of lab management experience in the biotech industry and academia, she has developed skills for coordinating and managing a team throughout small- and large-scale projects.

Alongside her project management, Jessica has gained skillsets in mammalian cell culture (including a primary cell, stem cell, and induced Pluripotent stem cells), and molecular biology techniques. At Rubhu Biologics she plans to continue to provide both research and administrative support to the company.